BIOMEDICAL SCIENCES INDUSTRY PARTNERSHIP OFFICE
WHAT SETS US APART
BMSIPO specialises in understanding our industry partners’ research and development interests, bringing together groups with the right capabilities, and crafting win-win collaboration models.Since our inception as a publicly-funded national platform in 2010, we have been forging strategic alliances that foster research and development (R&D) and clinical partnerships between industry partners and public research and healthcare institutions in Singapore.
TAILORED SOLUTIONS FOR ALL
Whether you’re a nimble Singapore startup or multi-national corporation with global networks, BMSIPO is your strategic ally.We take pride in developing partnerships that encompass the entire spectrum of R&D – from discovery research to technology development, pre-clinical to clinical development, translational clinical studies, and even manufacturing and process technology development. BMSIPO can be your strategic partner to help advance your R&D roadmap like never before.
“PRECISE has benefited immensely from BMSIPO's collective knowledge and experience in forging multi-institutional research projects and long-term strategic partnerships with the pharmaceutical and biomedical industry. We look forward to continuing our fruitful collaboration with BMSIPO to drive innovation and shape the future of healthcare.”
Professor Patrick Tan
Executive Director, PRECISE
“BMSIPO has been a tremendous support to Singapore Translational Cancer Consortium’s mission. Their networks to industry partners both international and in Singapore, and experience in structuring collaboration agreements has helped STCC accelerate our efforts.”
Professor Chng Wee Joo
Executive Director, STCC
“BMSIPO has been an invaluable partner to CPR and their unwavering support has been instrumental in accelerating collaborative research with the local scientific environment, especially for the dengue and COVID-19 projects with A*STAR. We're confident that our continued interactions with BMSIPO will yield greater future successes.”
Dr Hideaki Shimada
CEO of Chugai Pharmabody Research (CPR),
a wholly-owned subsidiary of Chugai Pharmaceutical
“TRUST is appreciative of BMSIPO's support to the research community. As the national data sharing and analytics platform for health-biomedical research, we value the partnership with BMSIPO to enable cutting-edge data driven innovations and partnerships for the benefit of our society.”
Mingshi Koh
Director, TRUST Office
Participants from publicly funded research institutions and national platforms shared work plans and ideas on strengthening collaboration.
Risky Businesses & How to Build Them
A panel comprising public health experts and academics who have successfully launched BioMedTech startups share their top tips.
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.
Get inspired by our #WomeninSTEM